Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Carol K. Kasper"'
Autor:
Sarah Williams-Blangero, Karin Haack, Vincent P. Diego, Meera Chitlur, Tom E. Howard, Bernadette W. Luu, Jerry S. Powell, Carol K. Kasper, Laura Almasy, Satish Kumar, Shelley A. Cole, Long V. Dinh, Henry Mead, Afshin Ameri, Raja Rajalingam, Marcio Almeida, Miguel A. Escobar, John Blangero
Publikováno v:
Blood. 134:2393-2393
The development of inhibitors against tFVIIIs represents a serious impediment to efficacious management of bleeding episodes in patients with hemophilia A (HA). It is therefore critical to understand the etiology of inhibitors to improve HA outcomes.
Autor:
Carol K. Kasper
Publikováno v:
Blood. 127(24)
In this issue of Blood , [Mazepa and colleagues][1] analyzed a nationwide US Centers for Disease Control and Prevention registry covering adult patients with severe hemophilia from 1998 to 2011 and identified two major issues: untreated chronic hepat
Autor:
Carol K. Kasper, C. H. Buzin
Publikováno v:
Haemophilia. 15:1181-1186
Some mosaic conditions may affect the haemophilia phenotype. Well-known instances include chromosomal mosaicism because of aneuploidy and pseudo-mosaicism because of varying patterns of X-chromosome inactivation. Chromosomal mosaicism in a chimera is
Autor:
Carol K. Kasper
Publikováno v:
Scandinavian Journal of Haematology. 33:147-154
Average pre-operative in vivo recoveries of factor VIII:C concentrate fell from 1967 to 1976, then improved, and fell again in the early 1980's. Average outpatient in vivo recoveries were studied from 1978-83; the lowest values for two of three brand
Autor:
Margaret W. Hilgartner, Eva A. Operskalski, null The Transfusion Safety Study Group, James W. Mosley, Marek J. Nowicki, Carol K. Kasper, Elizabeth Donegan, Louis M. Aledort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f15f68335dc39a85c6c3b332129ca521
https://doi.org/10.1159/000423825
https://doi.org/10.1159/000423825
Autor:
Jay N. Lozier, Carol K. Kasper, Zuben E. Sauna, Timothy C. Nichols, Chen Yanover, Tom E. Howard
Publikováno v:
Blood. 125(2)
Intron-22-inversion patients express the entire Factor VIII (FVIII)-amino-acid sequence intracellularly as 2 non-secreted polypeptides and have a positive “intracellular (I)-FVIII-CRM” status. Mutations conferring a positive I-FVIII-CRM status ar
Autor:
Elena Santagostino, Carol K. Kasper, C. R. M. Hay, P. M. Mannucci, P.O. Gorman, Donna DiMichele
Publikováno v:
Haemophilia. 8:9-12
Porcine factor VIII (pFVIII) is an effective haemostatic treatment for bleeding in selected patients with FVIII inhibitors. Its use is sometimes associated with a transient fall in platelet count and transfusion reactions, the risk of which may be re
Autor:
Barbara A. Konkle, Joseph Addiego, Benjamin Deulbesonic, George R. Buchanan, Brad Lewis, Linda G. Shaffer, Alton L. Lightsey, Ari J. Cohen, W. Keith Hoots, James L. Harper, John Bouhasin, Thomas H. Howard, Donald Mahoney, Gilbert C. White, Parvin Saidi, Carol K. Kasper, D. C. Talbert, Eric Larsen, David Lilligrap, Jack Lazerson, Martin J. Inwood, Bruce Ritchie, Elizabeth Kurczynski, Margaret Heisel, James Harper, J. Paul Scott, Robert L. Janco, Peter A. Kouides, Frederick Rickles, Alan Cohen, Anne Thomas, Indira Warrier, Prad Phatak, John D. Bouhasin, Cathy Rosenfield, S. R. Seitcher, David Green, Deborah L Brown, J. Heinreich Joist, Bridget Freeman, Mark Mancino, Edward H. Romond, Felicia Little, Leticia Valdez, Eric J. Werner, Patricia McCusker, Robert Bona, W. Paul Bowman, Louis Geeraerts, J. Teitel, Donna DiMichele, Catherine S. Manno, Jerry S. Powell, Bruce M. Ewenstein, Michael D. Tarantino, Dennis Gastineau, Richard Edwards, Thomas C. Abshire, Craig M. Kessler, Rachelle Nuss, Judy Wilimas, Gerald Gilchrist, Cindy Lessinger, Roshini Kulkarni, Jeannne M. Lusher, Margaret V. Ragni, Alberao Pappo, Sarah Hawk, Georges E. Rivard, Man Chiu Poon
Publikováno v:
Haemophilia. 7:235-241
The optimal treatment of patients with von Willebrand's disease (vWD) remains to be defined. Moreover, it has not been firmly established which, if any, commonly measured parameters of von Willebrand factor (vWF) protein in the plasma are useful in g
Autor:
Kathleen A. Hill, April Mengos, Xuemin Li, Miguel Tezanos Pinto, Diane Careri, William A. Scaringe, Stacy Roberts, Carol K. Kasper, Steve S. Sommer
Publikováno v:
Human Mutation. 17:511-519
Two germline retrotransposition mutations of recent origin were observed in 727 independent mutations (0.28%) in the human factor IX gene (F9) of patients with hemophilia B: 1) a 279 bp insertion in exon H originating from an Alu family of short inte
Autor:
Joni B. Drost, Ana Rebeca Jaloma-Cruz, William A. Scaringe, Diego F. Ossa, Xuemin Li, Steve S. Sommer, Carol K. Kasper
Publikováno v:
Human Mutation. 16:203-210
Two-base substitutions at each of two nucleotides in the factor IX gene (F9), but not part of CpG dinucleotides, were recently reported in a small population sample collected in Mexico, a significant observation of recurrent sites ("hotspots") of mut